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Breast cancer is one ofthe most commonly
diagnosed cancers in women (1,2). Breast
cancer incidence has been increasing steadi-
ly in most highly developed countries (3).
This trend has been attributed to risk fac-
tors such as more women smoking and
increased oral contraceptive use, as well as
early menarche, late menopause, family his-
tory, "delayed" childbearing, and potential
exposure to various environmental chemi-
cals (1,47). There is growing concern that
a large number of human-made chemicals
that have been released into the environ-
ment and that have been found to persist
and travel through the food chain, can
cause cancers in laboratory rodents (8-10).
Among these chemicals, pesticides, herbi-
cides, polychlorinated biphenyls (PCBs),
and polybrominated biphenyls (PBB) have
been found in both aqueous and soil matri-
ces and in the food chain associated with
these environments (8-11).
Many of these chemicals have accumu-
lated in animals and humans through sever-
al routes of exposure. These accumulated
lipophilic halogenated hydrocarbons have
been speculated to play a causative role in
various human diseases (12-18). PCBs are
embryotoxic in mink, neurotoxic during
development in animals, and can alter
uterine progesterone and progesten recep-
tors (17,19). Although some bioassay data
on rodents suggest that many ofthese pes-
ticides and chemicals, such as the PCBs
and PBBs, are carcinogens, in vitro and in
vivo initiation-promotion bioassays sug-
gest that most ofthese chemicals are acting
as tumor promoters via nongenotoxic or
epigenetic mechanisms (20).
Due to their lipophilic nature, these
chemicals readily accumulate in animal
and human tissues. Human breast tissue
appears to be a site for some of the accu-
mulation of these chemicals. Because of
the estrogenic activity of some of these
chemicals.and the bioaccumulation in
human breast tissue, epidemiological stud-
ies have been performed to test if DDT
metabolites and PCBs might be etiological
agents ofhuman breast cancers. Studies to
date have not resolved the hypothesis that
this class ofpollutant, "estrogenlike" chem-
icals, have an influence on human breast
cancer (21-34).
Because carcinogenesis is a multistep,
multimechanism process, consisting of the
operational steps of initiation, promotion,
and progression (35), and because both
genotoxic and epigenetic mechanisms play a
role in this complex process, it is important
to consider these concepts in the design and
interpretation ofboth animal bioassays and
epidemiological studies of cancer. One of
the facts related to the concern that these
chemicals be assessed for their carcinogenic
potential on human breast tissue is that
data showing that most of these chemicals
(DDT, PCB, PBB, dieldrin, etc.) are not
genotoxic in rodent cells but are rather
effective tumor promoters ofliver cancers in
rodents (36-38).
In addition, most tumor promoters (e.g.,
phorbol esters, phenobarbital, saccharin,
TCDD, DDT, dieldrin, toxaphene, PCBs,
PBBs) have the ability to inhibit, in a
reversible manner, gap junctional intercellu-
lar communication (GJIC) in various cells,
in vitro, at noncytotoxic but at concentra-
tions sufficient (e.g., threshold concentra-
tions) to inhibit GJIC (37-41). Inhibition
of the communication of ions and small
molecular weight molecules through these
transmembrane protein channels between
contiguous cells has been postulated to
release initiated cells from the suppressing
effects of signals passing from surrounding
normal cells (42,43). Therefore, we
designed studies to determine if several of
the environmental chemicals found in the
Great Lakes are able to inhibit GJIC in nor-
mal human breast epithelial cells, either
alone or in specific combination with other
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chemicals. Results clearly indicate that these
chemicals could block GJIC in these cells,
and the concentrations needed to do so, in
vitro, were lower when these chemicals were
given in certain mixtures.
Materials and Methods
CeUlcultures. Normal human breast epithe-
lial cells (HBEC) were obtained from
reduction mammoplasty tissue specimens
from seven patients (44). Tissue specimens
were minced into small pieces with scalpels,
then digested in collagenase-type IA (Sigma
, St. Louis, Missouri) solution (1 g tissue/10
mg of collagenase in 10 ml medium) at
37°C in a waterbath for 16-18 hr. The
digested tissue solution was then cen-
trifuged to remove the collagenase solution.
Cellular pellets were washed once with
MSU-1 medium (44), then resuspended in
the MSU-1 medium supplemented with
5% fetal bovine serum (FBS; GIBCO-
BRL, Gaithersburg, Maryland). The cells
were plated in two flasks (150 cm2). After
2 hr incubation, the cells (or aggregates)
which remained in suspension were trans-
ferred to 4-6 flasks (75 cm2) to reduce the
number of attached fibroblasts. After
overnight incubation, the medium was
changed to the FBS-free MSU-1 medium.
The MSU-1 medium was changed once
every 2 days for 1 week. The cells were cul-
tured in D-medium:MCDB (1:1; Sigma)
without FBS (MSU-1). This modified
Eagle's minimal essential medium was sup-
plemented with recombinant human epi-
dermal growth factor (1 ng/ml), insulin (10
pg/mI), hydrocortisone (1 ng/ml), 17b-
estradiol (10 nM), and 0.4% bovine pitu-
itary extract. All cells were grown at low
passage at 37°C and 5% CO2 in a humidi-
fied incubator. The cells were passaged by
trypsinization.
The first passage of HBEC, recovered
from liquid nitrogen, was plated in MSU-1
medium supplemented 5% FBS. After 4
hr incubation, the cells which remained in
suspension were transferred to new plates
(100 mm2) in FBS-free MSU-1 medium
supplemented with 0.4% bovine pituitary
extracts (Pel-Freez, Roger, Arkansas),
where they gave rise to a second morpho-
logical type ofcells (44). We used this sec-
ond morphological type of cell (2-3 pas-
sages) for the experiments described here.
Chemicals. PCBs, PBBs, 4,4'-DDT,
dieldrin, and toxaphene were obtained
from Chem Service Co. (West Chester,
Pennsylvania). Additional reagents were
purchased from Sigma.
Cytotoxicity test. Cells (1 x 104) were
plated in triplicate in 96-well, flat-bottomed
microtiter plates. Twenty-four hours later,
the medium was changed and fresh medi-
um with the test chemicals was added.
Twenty-four hours after treatment, the
medium was removed, and cells were
washed with warm phosphate-buffered
saline (PBS) three times and then 200 ml of
neutral red medium (50 mg/ml in growth
medium) was added to each well. Plates
were incubated at 37'C for 2 hr, and then
cells were solubilized with 1% acetic acid in
50% ethanol for 20 min. We determined
absorbance at 540 nm and 630 nm for each
well using 96-well plate reader (Bio-Tek
Instruments, Winooski, Vermont).
HBEC type II cells were cultured in
35-mm dishes to 90-100% confluence,
then treated with PCBs, PBBs, DDT,
toxaphene, and dieldrin. We dissolved
2,2',3,3',4,4'-HCB, 2,2'4,4',5,5'-HBB,
2,2',4,4',5,5'-HCB in dimethylsulfoxide
and 3,3',4,4',5,5'-HCB, 3,3'4,4'5,5'-
HBB in dimethylsulfoxide:acetone (1:1).
Dieldrin and 4,4'-DDT were dissolved in
ethanol; toxaphene was dissolved in ace-
tone. The maximum volume ofthe chemi-
cals applied to the cells was 5 pl/ml.
Control cells were treated with each solvent
(5 pl/ml).
Gapjunctional intercellular communi-
cation assays. We measured gap junction-
mediated intercellular communication
using the dye transfer technique (45). The
cultures were rinsed with PBS, and then 2.0
Table 1. Dose-dependent effects of PCBs, PBBs, DDT, dieldrin, and toxaphene on gap junctional intercel-
lular communication in normal human breast epithelial cells
Chemical
2,4,5-HCB
3,4,5-HCB
2,4,5-HBB
3,4,5-HBB
2,3,4-HCB
DDT
Dieldrin
Toxaphene
Dose (pM)
D
14
28
56
70
0
14
28
56
0
4
8
16
32
64
0
20
40
80
160
0
9
18
35
70
0
6
13
25
50
100
0
3
6
13
25
50
0(mg/ml)
1.25
2.50
5.00
10.00
No. of cells
27
27
28
21
22
27
23
25
22
37
25
28
28
27
28
37
27
28
28
27
37
22
20
22
24
24
24
24
24
24
24
24
24
24
24
24
24
20
20
20
20
20
Rate of dyetransfer/mina
4.73 ± 1.84
4.40 ± 1.64
3.57 ± 1.58
4.29 ± 1.82
1.56±1.00*
4.73 ± 1.84
5.37 ± 2.23
4.46 ± 1.42
5.95±2.60
5.56 ± 1.04
4.92 ± 0.63
4.84± 1.85
4.46 ± 1.23*
2.01±1.24*
1.68 ± 0.82*
5.56 ± 2.04
5.74± 1.56
8.02 ± 2.07
5.43 ± 1.92
6.81 ± 2.03
5.56 ± 2.04
5.92 ± 2.30
4.75 ± 2.06
4.52 ± 2.43
0.14 ± 0.07*b
4.51 ± 0.90
4.43±0.54
3.69±1.10
0.76±0.35
0.31±0.07*
0.33 ± 0.17*
4.51 ± 0.90
4.04 ± 0.24
3.27 ± 1.87
1.53 ± 0.91*
1.21 ± 1.36*
0.80 ± 0.39*
6.02 ± 1.61
5.31 ± 1.46
5.21 ± 2.20
2.10 ± 0.85*
0.69 ± 0.42*
% of control
100
93
75
91
33
100
113
94
126
100
89
87
80
36
30
100
103
144
98
120
100
106
85
81
3
100
98
82
17
7
7
100
90
73
34
27
18
100
88
87
35
11
"Values represent means ± SD ofthe recovery rate offluorescence dye per minute obtained from fluores-
cence redistribution after photobleaching assayfor 9 min.
bCytotoxicity was observed.
*Significantly differentfrom vehicle control (p<0.05).
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ml PBS containing 0.05% Lucifer yellow
DH-rhodamine dextran (Sigma) was added
to the petri dishes. The dye was loaded into
the primary recipient cells by making six
scrape lines on the monolayer with a sharp
surgical blade. After 3 min of loading the
cells with the dye, the solution was removed
and the cells were washed with PBS. The
plates were examined under Nikon epifluo-
rescence inverted microscope with an
appropriate filter.
To measure gap junctional communi-
cation using the fluorescence redistribution
after photobleaching (FRAP) assay, after 24
hr of growth, the cells were washed with
PBS containing calcium (0.9 mM) and
magnesium (0.5 mM; PBS/Ca/Mg) and
stained with 6-carboxyfluorescein diacetate
for 9 min (46). The plates were then
washed several times with PBS/Ca/Mg.
The FRAP assay was performed using the
Ultima image analyzer (Meridian Co.,
Okemos, Michigan). Individual cells were
photobleached with a 488 nm laser and
recovery of fluorescence intensity moni-
tored at 3-min intervals for 9 min.
Fluorescence intensity was corrected for
photobleaching, which occurs during scan-
ning ofthe control areas.
Immunofluorescent staining ofgap
junctions. We immunostained connexin 43
(Cx43)-containing gap junctions in HBEC
using a rabbit polyclonal antibody against
Cx43. After treatment, the cells were fixed
in cold 50% methanol and 50% acetone
for 3 min and rehydrated with PBS; subse-
quently, nonspecific sites were blocked
with 10% normal goat serum (NGS) in
PBS for 30 min at room temperature. The
cells were incubated with anti-Cx43 dilut-
ed 1:100 in PBS for overnight at 40C,
washed three to four times with PBS, and
then incubated with rhodamine-conjugated
goat anti-rabbit IgG Fab2 fraction Uackson
Immuno Research Laboratories, West
Grove, Pennsylvania) diluted 1:50 in PBS
for 30 min at room temperature. The cells
were washed extensively with PBS, and
coverslips were mounted in Poly-
aquamount (Polysciences, Inc., Warring-
ton, Pennsylvania). The cells were viewed
and photographed using the Ultima image
analyzer.
Proteins were extracted from HBEC in
25 cm2 flasks by treatment with hypotonic
buffer [composed of 375 pl of 10 mM
Tris-HCl, pH 7.5; 1 mM phenylmethyl-
sulfonyl fluoride (PMSF); and 10 mM
iodoacetamide] and cocktail solution con-
taining 1 pM leupeptin, 1 pM antipain,
0.1 pM aprotinin, 0.1 mM sodium ortho-
vanadate, 5 mM sodium fluoride, and then
alkalinized with 550 pl 40 mM NaOH.
After sonication at three 10-sec pulses
from a probe sonicator, cell lysates were
centrifuged at 40C for 30 min to obtain a
fraction ofintegral membrane components
for Cx43 analysis. The pellets were washed
in the hypotonic buffer and solubilized in
10% sodium dodecyl sulfate (SDS), 10
mM Tris-HCl, and 1 mM PMSF, pH 7.5.
We determined protein concentrations
using the DC protein assay (Bio-Rad
Corp., Richmond, California). Proteins
were separated on 12.5% SDS polyacryl-
c _ i
4. "'Vi
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Figure 1. Dose-responsive inhibition of gap junctional intercelluar communication in normal human breast epithelial cells treated with different concentrations of
DDT using the scrape-loading dyetransfer assay. (A) Control; (B) 6 pM;(C) 13 pM;(D) 25 pM;(E) 50 pM;(F) control (phase-contrast).
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Heights, Illinois). The membranes were
exposed to X-ray film for 30 sec.
Alkaline phosphatase treatment.
Samples (20 jig) of the alkali-resistant
membrane protein fractions were diluted
twofold with reaction buffer (50 mM Tris,
pH 8.5; 2 mM PMSF; 0.1% ,B-mercap-
toethanol; 8 mM MgCl2) and incubated
with and without 10 U of calf intestine
Table 2. Time-course effects of PCBs and toxaphene on gap junctional intercellular communication in
human breastepithelial cells
Chemical (dose) Hr No. of cells Rate ofdyetransfer/mina % of control
2,4,5-HCB 0 36 5.20 ± 2.03 100
(28 pM) 3 20 6.38± 2.01 123
6 20 2.13± 1.04* 41
12 21 3.46±2.11* 67
24 19 4.50± 1.31 87
3,4,5-HCB 0 36 5.20 ± 2.03 100
(56 pM) 3 22 5.74 ± 1.33 106
6 19 5.52±2.46 103
9 20 5.35± 2.09 103
12 21 6.51 ± 2.91 125
24 19 2.21 ± 1.24* 43
2,3,4-HCB 0 30 6.14 ± 2.08 100
(56 pM) 0.5 24 5.04 ± 2.45 82
3 24 1.39 ± 0.48* 23
6 24 1.65 ± 0.90* 27
12 24 4.50 ± 1.90 73
2,4,5-HBB 0 30 6.14 ± 2.08 100
(32 pM) 0.5 24 6.98 ± 2.90 114
3 24 2.65 ± 0.71* 43
6 24 3.56 ± 0.98* 58
12 24 3.12± 0.88* 51
24 24 5.03 ± 1.53 82
3,4,5-HBB 0 30 6.14 ± 2.08 100
(16 pM) 0.5 24 5.68 ± 2.24 93
3 24 4.07 ± 1.77* 66
6 24 5.73 ± 1.66 93
12 24 4.25 ± 2.13* 69
24 24 4.89 ± 2.17 80
'Values represent means ± SD ofthe recovery rate offluorescence dye per minute obtained from fluores-
cence redistribution after photobleaching assayfor9 min.
*Significantly differentfrom 0-hr treatment(p<0.05).
Table 3. Time-course effects of DDT, dieldrin, and toxaphene on gap junctional intercellular communica-
tion in normal human breastepithelial cells
Chemicals (dose) Hr No. of cells Rate ofdyetransfer/mina % of control
Toxaphene 0 20 4.22 ± 1.52 100
(10 pg/mI) 0.5 21 1.04 ± 0.52* 25
3 21 2.46± 1.54* 62
6 21 2.51 ± 1.24* 59
12 21 0.75± 0.33* 18
24 20 0.72 ± 0.53* 17
DDT(5OpM) 0 30 6.14 ± 2.08 100
3 24 4.36 ± 2.03* 71
6 24 3.43± 1.87* 56
12 24 3.00±1.72* 49
24 24 4.65± 1,31* 76
Dieldrin 0 30 6.14 ± 2.08 100
(25 pM) 3 24 1.86 ± 0.71* 30
6 24 1.84 ± 0.96* 30
12 24 1.46 ± 0.59* 24
24 24 1.14 ± 0.74* 19
aValues represented the mean ± SD from the recovery rate of fluorescent dye per minute obtained from
fluorescence redistribution after photobleaching assayfor9 min.
*Significantly differentfrom 0-hrtreatment(p<0.05).
alkaline phosphatase (10,000 U/ml; New
England Biolab, Beverly, Massachusetts)
for 2 hr at 370C. The proteins in the reac-
tions were separated by SDS-PAGE and
then transblotted to PVDF membranes for
Western blot analysis.
Northern blottingfor Cx43 mRNA.
We isolated total RNA from HBEC by
guanidium thiocyanate extraction (48).
The isolated RNA was separated by elec-
trophoresis on 1.2% agarose-6.7%
formaldehyde gels, transferred onto a
nylon membrane (Hybond N+; Amersham
Co., Arlington Heights, Illinois). The
membranes were dried for 2 hr under vac-
uum at 80°C, prehybridized for 1 hr at
630C, and then hybridized with a digoxi-
genin-dUTP-labeled Cx43 cDNA using a
random-primed DNA labeling kit
(Boehringer Mannheim, Indianapolis,
Indiana). The hybridized RNA bands were
detected on film by exposure to light gen-
erated by chemiluminiscent reaction using
the anti-dioxigenin-AP antibody and
Lumi-phos 530.
Statistics. We analyzed data by
ANOVA (analysis ofvariance). The signifi-
cance level (0.05) is compared with the cal-
culated F-value. If there was a difference
among groups, data were further analyzed
to determine where the difference was by
post-hoc Dunnett's t-test at a significance
level ofp<0.05.
Results
Dose Selection Using Cytotoxicity
Assay
To determine the cytotoxicity of these
chemicals on HBEC, we examined the
uptake ofneutralred dye in viable cells using
a microplate reader (OD 540 nm and 630
nm). We observed cytotoxicity after a 24-hr
exposure to the following mixture ofchemi-
cals above these dose levels: 2,2',4,4',5,5'-
HCB, 70 jiM; 3,3',4, 4',5,5'-HCB, 56 PM;
for 2,2',4,4',5,5'-HBB, 64 pM;
3,3',4,4',5,5'-HBB, 160 pM; 2,2',3,3',
4,4',-HCB, 70 pM; DDT, 100 pM; dield-
rin, 100 pM; and toxaphene, 10 pg/ml
(mixture of compounds). Because it is
important to measure a chemical's effect on
GJIC at noncytotoxic doses, we determined
the maximal noncytotoxic doses. On the
basis of these dose levels, we selected doses
to be used at a twofold dilution, up to the
maximum noncytotoxic levels.
Effects on GJIC
Among PCBs and PBBs, 2,2',4,4',5,5'-
HCB (0-70 pM) and 2,2',4,4',5,5'-HBB
(0-64 pM) inhibited GJIC in HBEC in a
dose-dependent manner after a 90-min
treatment, whereas the coplanar structures
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amide gels and transferred to PVDF mem-
branes at 20 V for 16 hr. We detected
Cx43 using anti-connexin 43-specific mon-
oclonal antibody (Zymed, Inc., San
Francisco, California), followed by incuba-
tion with horseradish peroxidase (HRP)-
conjugated secondary antibody and detect-
ed with the ECL chemiluminiscent detec-
tion reagent (Amersham Co., Arlington
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of these chemicals, 3,3',4,4',5,5'-HCB
(0-56 jiM) and 3,3',4,4',5,5'-HBB (0-160
pM) did not inhibit GJIC. 2,2',3,3',4,4'-
HCB (0-70 PM) also slightly inhibited
GJIC in a dose-dependent manner (Table
1). DDT (0-100 PM), dieldrin (0-50 pM),
and toxaphene (0-10 pg/ml) inhibited
GJIC in a dose-dependent manner after a
90-min treatment, as assayed by fluores-
cence dye transfer (Fig. 1).
Dose levels of 70 pM 2,2',4,4',5,5'-
HCB, 70 pM 2,2',3,3',4,4'-HCB, 64 pM
2,2',4,4',5,5'-HBB, 25 pM-100 pM
DDT, 12.5-50 pM dieldrin, and 5-10
pg/ml toxaphene significantly inhibited
GJIC in HBEC (p<0.05).
2,2',4,4',5,5'-HCB (28 pM), 3,3',4,
4',5,5'-HCB (56 pM), 2,2',3,3',4,4'-
HCB (56 pM), 2,2',4,4',5,5'-HBB (32
PM), and 3,3',4,4',5,5'-HBB (16 pM)
inhibited GJIC in a time-dependent man-
ner as measured by the fluorescence dye
transfer assay (Table 2). Significant inhibi-
tion ofGJIC was observed in HBEC treat-
ed with 2,2',4,4',5,5'-HCB 6-12 hr after
treatment, 3,3',4,4',5,5'-HCB 24 hr after
treatment, 2,2',3,3',4,4'-HCB 3-6 hr after
treatment, 2,2',4,4',5,5'-HBB 3-12 hr
after treatment, and 3,3',4,4',5,5'-HBB
3-12 hr after treatment (p<0.05). After 24-
hr exposure to these chemicals, the rates of
dye recovery were restored to 70-80% of
control levels (Table 2).
The time-dependent manner by which
DDT (50 PM), dieldrin (25 pM), and
toxaphene (10 pg/ml) inhibited GJIC in
HBEC is shown in Table 3. Dieldrin and
toxaphene inhibited GJIC by 70-80% after
3 hr and 30 min of exposure in HBEC,
respectively. Recovery of GJIC was not
observed within 24 hr. However, although
DDT inhibited GJIC by 50% after 12-hr
exposure, recovery ofGJIC to 75% ofcon-
trol levels was seenwithin 24 hr.
DDT (6 pM), dieldrin (3 pM),
2,2',4,4',5,5'-HCB (14 pM), and 2,2',4,
4',5,5'-HBB (8 pM) did not inhibit GJIC
after a 90-min treatment in HBEC at the
lower dose levels used, compared with con-
trols (Fig. 3). However, among these chem-
icals, the mixtures of DDT (6 pM) and
2,2',4,4',5,5'-HCB (14 jiM), as well as
dieldrin (3 pM) and 2,2,4,4',5,5'-HCB
(14 pM), significantly inhibited GJIC
(p<0.05; Figs. 2D-F, 3).
Connexin 43 Proteins
Membrane-localized gap junctional plaques
were readily apparent in control cells (Fig.
4A). Cells treated for 90 min with dieldrin
(25 pM; Fig. 4C), 2,2',4,4',5,5'-HCB (28
pM; Fig. 4D), DDT (50 pM; data not
shown) in membrane plaques ofgap junc-
tion were missing from the cell mem-
branes. This change was accompanied by
numerous cytoplasmic spots (Fig. 4D),
suggestive of gap-junction internalization.
Furthermore, fewer plaques in cells were
detected after treatment with the mixtures
ofdieldrin (3 pM) and 2,2',4,4',5,5'-HCB
(Fig. 4I), as well as DDT (6 pM) and
2,2,4,4',5,5'-HCB (14 pM). Interestingly,
.1
WV
V
.I
Figure 2. Inhibition of gap junctional intercelluar communication in normal human breast epithelial cells treated with mixtures using the scrape-loading dye
transfer assay. (A) control; (B) DDT, 6 pM; (C) 2,4,5,-hexachlorobiphenyl (HCB), 14 pM; (D) dieldrin, 3 pM; (E) 3 pM dieldrin + 14 pM 2,4,5-HCB; (F) 6 pM DDT + 14
pM 2,4,5-HCB; (G) 3 pM dieldrin + 8 pM 2,4,5-HBB.
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NC g .2S; "'
DMSO
DMSO:Acetone0:1)
EtOH
DDTt6 iM)
Dieldrin 13 tM)
2,4,5-HCB (14 iM)
2,4,5-HBB (8 pM)
2,4,5-HCB PgLM)
DDT+2,4,5-HCB
DDT+2,3,4-HCB
DDT+245 2HBB
Dieldrin+2,4,5-HCB
Dieldrin +2,4,5-HBB
Dieldrin + 23,4-lHCB
0 3 6 9 12
Rate ofdyetransfer/min
Figure 3. Inhibition of gap junctional intercelluar
communication in normal human breast epithelial
cells treated with mixtures using the fluorescence
redistribution after photobleaching assay. NC,
nontreatment control; EtOH, ethanol (0.1%).
*Significantly different from vehicle control
(p<0.05).
in cells treated with dieldrin, the subcellu-
lar localization ofgap junction proteins was
perinuclear (Fig. 4D).
Using Western blotting, we examined
the changes in Cx43 protein levels, as well
as the degree of phosphorylation of the
Cx43 protein following treatment of the
cells with these environmental pollutants.
In HBEC, two major bands were detected
with a monoclonal antibody specific for
Cx43 (Fig. 5B).
Treatment of cell extracts with calf
intestinal alkaline phosphatase before pro-
tein electrophoresis resulted in the disap-
pearance of the upper band on Western
blots (Fig. 5C). This indicated that the
upper band was the phosphorylated, and
the lower band was the nonphosphorylated
species ofCx43.
Cells treated with the vehicle controls
(ethanol or DMSO:acetone = 1:1) resulted
in a slight reduction ofthe amount ofphos-
phorylated Cx43 with no apparent loss of
GJIC (Fig. 5A) as compared to the untreat-
ed controls (Fig.. 5B). Cells treated with
DDT, dieldrin, toxaphene, and 2,4,5,2',
4',5'-HCB at doses which lead to reduced
Figure 4. Indirect immunofluorescent staining of
connexin 43 in normal human breast epithelial
cells treated with mixtures or single chemicals.
(A) Control; (B) no primary antibody; (C) 2,4,5-
hexachlorobiphenyl (HCB), 28 pM; (D) dieldrin, 25
pM; (E) control; (F) dieldrin, 3 pM; (G) 2,4,5-HCB,
14 pM; (H) 3 pM dieldrin + 14 pM 2,4,5-HCB.
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Figure 5. Western blot analysis of connexin 43 protein in the cell membrane of a normal human breast
epithelial cell. (A) Single treatment: lane 1, vehicle control (ethanol 0.1%); lane 2, vehicle control
(dimethylsulfoxide:acetone, 1:1); lane 3, 50 pM DDT; lane 4, 25 pM dieldrin treatment; lane 5, toxaphene
(10 pg/ml); lane 6, 56 pM 2,4,5-hexachlorobiphenyl (HCB); lane 7, 70 pM 2,4,5-hexabrominated biphenyl
(HBB). (B) Mixture treatment: lane 1, nontreatment control; lane 2,6 pM DDT; lane 3,3 pM dieldrin; lane 4,
14 pM 2,4,5-HCB; lane 5, 6 pM DDT + 14 pM 2,4,5-HCB; lane 6, 3 pM dieldrin + 14 pM 2,4,5-HCB; lane 7, 3
pM dieldrin + 8 pM 2,4,5-HBB; lane 8, 8 pM 2,4,5-HBB. (C) Calf intestinal alkaline phosphatase treatment:
lane 1, untreated membrane fraction; lane 2, mock treatment without enzyme; lane 3, membrane fraction
treated with calf intestinal alakaline phosphatase (10 U/ml); P, phosphorylated band; NP, nonphosphory-
lated band.
GJIC, display reduced levels of the phos-
phorylated Cx43 species (Fig. 5A) as com-
pared to vehicle controls. Cells treated with
DDT, dieldrin, and 2,4,5,2',4',5'-HBB at
doses which do not affect GJIC display lev-
els of phosphorylated Cx43 similar to that
ofthe vehide controls (Fig. 5B). Cells treat-
ed with 2,4,5,2',4',5'-HCB (14 IiM) dis-
played a slight increase in the phosphorylat-
ed Cx43 band (Fig. 5B). Treatment of cells
with mixtures of DDT (6 jIM ) and
2,4,5,2',4',5'-HCB (14 pM), at doses
which singly do not affect GJIC, results in
further reduction of the phosphorylated
Cx43 levels (Fig. 5B) and greatly reduced
GJIC. An apparent loss of the phosphory-
lated Cx43 species was observed in cells
treated with a mixture of dieldrin (3 IiM)
and 2,4,5,2',4',5-HCB (14 pM; Fig. 5B).
To determine if treatment with these
environmental halogenated hydrocarbons
altered the level of connexin gene tran-
scripts, the steady-state levels of Cx43
mRNA were analyzed by Northern blot-
ting cells treated with each chemical for 90
min. The data (Fig. 6) showed no signifi-
cant difference between control cells and
these environmental pollutant-treated cells,
alone or in mixture.
Discussion
It is assumed that inhibition of gap junc-
tional intercellular communication is a
mechanistic marker for several toxicological
endpoints, such as teratogenesis, tumor pro-
motion, and reproductive and neurological
toxicity (20). Therefore, the experiments
reported here, using several pollutants
known to inhibit GJIC in rodents cells in
vitroand to be either teratogens, tumor pro-
moters, neurotoxicants, or reproductive tox-
icants in animals (10,17,19), have shown
that these chemicals could inhibit GJIC in
normal human breast epithelial cells. These
studies were prompted by some epidemio-
logical evidence that human exposure to
these chemicals via the food chain might be
responsible for several human health effects,
including breast cancer (21-34).
This study has shown that DDT, dield-
rin, toxaphene, and PCB and PBB con-
geners could inhibit GJIC in normal
human breast epithelial cells. Furthermore,
these chemicals inhibited GJIC in a
reversible manner indicating the effect was
not due to a cytotoxic effect and that no-
effect or threshold levels existed for each
chemical. Interestingly, specific chemicals,
which individually did not inhibit GJIC at
a given concentration, could, when mixed
with another chemical which also did not
inhibit GJIC at a certain concentration,
interacted to inhibit GJIC.
These studies also demonstrated some
differences, as well as some similarities, in
the behavior of the normal human breast
epithelial cells when compared to rat liver
epithelial cells (WB-F344 oval cells). For
example, in WB-F344 cells, TPA treatment
at a dose level of 10 ng/ml significantly
inhibited GJIC (39), but 360 ng/ml TPA
had no effect on GJIC in normal human
breast epithelial cells (data not shown). On
the other hand, DDT, dieldrin, and
toxaphene inhibited GJIC in normal human
epithelial cells in a manner similar to rat
liver WB-F344 cells (39,40). Furthermore,
2,2',4,4',5,5'-HCB and 2,2',4,4',5,5'-HBB
inhibited GJIC in normal human breast
epithelial cells, whereas coplanar analogs of
these chemicals, 3,3 ,4,4,5,5 -HCB and
3,3',4,4',5,5'-HBB, did not inhibit GJIC at
noncytotoxic concentrations. These observa-
tions suggest that normal human breast
epithelial cells behaved similarly to human
teratocarcinoma cells, Chinese hamster V79
cells, and rat liverepithelial cells when tested
with these chemicals (41,48-52).
To determine how these chemicals
might have inhibited GJIC in these cells,
we examined Cx43 protein in cells after
treatment with DDT, dieldrin, toxaphene,
2,2'4,4',5,5'-HCB, and 2,2',4,4',5,5 -HBB
by immunofluorescent staining. A reduc-
tion in the number ofgap junction plaques
was observed (Fig. 4). Interestingly, in cells
treated with dieldrin, the gap junction pro-
teins were observed in the perinuclear area
of the cells, suggesting a problem in the
trafficking ofthe gap junction protein. To
determine ifand how treatment ofthe nor-
mal human breast epithelial cells might
affect the phosphorylation status of Cx43,
Western blots were performed. The con-
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Figure 6. Northern blot analysis of steady-state connexin 43 mRNA in normal human breast epithelial cell
treated with several pesticides, PCBs and PBBs, alone or as mixtures. Lane 1, untreated control; lane 2,
vehicle control (ethanol 0.1%); lane 3, vehicle control (dimethylsulfoxide: acetone, 1:1); lane 4, 10 pg/ml
toxaphene; lane 5, 6 pM DDT; lane 6, 50 pM DDT; lane 7, 3 pM dieldrin; lane 8, 25 pM dieldrin ; lane 14 pM
9, 2,4,5-hexachlorobiphenyl (HCB); lane 10, 56 pM 2,4,5-HCB; lane 11, 8 pM 2,4,5-hexabrominated biphenyl
(HBB); lane 12, 40 pM 2,4,5-HBB; lane 13, 6 pM DDT + 14 pM 2,4,5-HCB; lane 14, 3 pM dieldrin + 14 pM
2,4,5-HCB; lane 15,3 pM dieldrin + 8 pM 2,4,5-HBB. GADPH, glyceraldehyde-3-phosphate dehydrogenase.
centration of the chemicals that inhibited
GJIC indicated alterations in the phospho-
rylation patterns of these proteins when
compared to the control cells (Fig. 6).
Several reports have shown that some
tumor promoters can induce hyper- or
hypophosphorylation of Cx43, which cor-
related with GJIC (38-40). For example,
TPA induced hyper-phosphorylation of
Cx43, which altered the subcellular local-
ization of the Cx43 protein under condi-
tions that inhibited GJIC in rat liver WB-
F344 and LARcell lines (38-40).
Immunoblot analyses of Cx43 in nor-
mal human breast epithelial cells revealed at
least two major protein bands (phosphory-
lated and nonphosphorylated bands; Fig. 5).
The pattern ofthe different Cx43 bands in
normal human breast epithelial cells appears
to be different from that seen in normal rat
liver WB -F344 cells (unpublished data).
DDT, dieldrin, and toxaphene induced
hypophosphorylation of Cx43 in normal
human breast epithelial cells at concentra-
tions that affected GJIC. There was no
change in the steady-state levels of Cx43
mRNA after treatment with these chemi-
cals, alone or in combination (Fig. 6).
Comparison of the Cx43 phosphorylation
patterns and Cx43 immunostaining in the
case of dieldrin mixed with 2,4,5-HCB
leads to the hypothesis that 2,4,5-HCB
enhances the effects of dieldrin-mediated
hypophosphorylation and that 2,4,5-HCB's
major effect occurs during plaque internal-
ization. This is proposed because 2,4,5-
HCB alone induces little if any Cx43
hypophosphorylation compared to vehicle
controls. However, 2,4,5-HCB (GJIC-
affecting dose)-treated cells display little
Cx43 membrane staining. Dieldrin induces
hypophosphorylation and loss of Cx43
membrane plaques (at GJIC-affecting dose).
When cells are treated with dieldrin and
2,4,5-HCB mixtures (at GJIC-nonaffecting
dose), the phosphorylated species essentially
disappears. These results suggest that these
environmental halogenated hydrocarbons
might alter Cx43 proteins, post-translation-
ally, rather than transcriptionally.
One ofthe recent concerns ofmany of
the environmental halogenated hydrocar-
bons is that they might have estrogenic
activity, and it is the estrogenlike properties
of these chemicals that are responsible for
their toxic effects. Soto et al. (22) showed
that pesticides such as DDT, dieldrin, and
toxaphene are estrogenic in MCF-7 human
breast cancer cells. Other groups have sug-
gested a structural relationship to steroid
hormones, particularly estrogen and PCB
congeners (21). Because humans are
exposed to many of these kinds of estro-
genlike chemicals (natural and human-
made) in their food supply and because
several combinations of these chemicals in
mixtures can affect GJIC when no single
chemical could, the theory that these
chemicals might be tumor promoters of
human breast cancers could be entertained
as possible contributors to the multistage
nature ofhuman carcinogenesis.
However, caution must be used in the
interpretation of these data. First, human
carcinogenesis, like animal carcinogenesis,
is a multistep, multimechanism process,
involving genotoxic and nongenotoxic
mechanisms. The chemicals used in these
studies are not genotoxic (40,51) but act
via epigenetic mechanisms involving some
alterations in signal transduction, such as
phosphorylation or dephosphorylation of
proteins, ultimately modulating intercellu-
lar communication which regulates cell
proliferation/differentiation homeostasis
(20). Therefore, these chemicals are proba-
bly not tumor initiators but tumor pro-
moters. To be tumor promoters in animals
or humans, these chemicals must be pre-
sent at or above threshold levels ito inhibit
GJIC and must be acting on preexisting,
initiated cells for long periods oftime on a
regular exposure basis (52).
Recent studies in our laboratory have
shown that the normal human breast
epithelial cells used (44) in these studies
(type II) do not express the estrogen recep-
tor. Therefore, the chemicals used in our
studies inhibited GJIC via nonestrogen
receptor mechanisms, even though these
chemicals are estrogenlike compounds.
What is not known is whether an initiated
human breast epithelial cell would behave
differently from these normal breast epithe-
lial cells when exposed to these chemicals.
Future studies will have to be done on nor-
mal human breast epithelial cells that
express estrogen receptors.
In summary, normal human breast
epithelial cells exhibit functional GJIC
(44), which can be inhibited by noncyto-
toxic concentrations ofDDT, dieldrin, and
toxaphene, as well as 2,2'4,4',5,5'-HCB
and 2,2',4,4',5,5'-HBB, in a dose-depen-
dent and reversible fashion, with each
showing a no-effect or threshold level.
Specific mixtures oftwo ofthese chemicals
showed that, while each alone did not
inhibit GJIC, the mixtures did. Therefore,
while these chemicals can inhibit GJIC in
normal human breast epithelial cells in
vitro, it remains to be determined if they
can inhibit GJIC in vivo and ifthese chem-
icals would affect initiated human breast
epithelial cells the same or differently from
the way they affect normal cells. Since the
inhibition of GJIC has been hypothesized
to play a role in the promotion/progression
phases ofcarcinogenesis (35), and since the
environmental toxicants used in these stud-
ies do inhibit GJIC in animal cells in
which they also act as tumor promoters,
these studies indicate that these chemicals
might exert some human health effects if
they meet all the conditions to inhibit
GJIC in vivo.
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